TAOX — Tao Synergies

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The...

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Industry

FINANCE SERVICES

Sector

Technology

Exchange

NASD

First trade date

2020-12-07

The interactive platform loads with JavaScript. Research tools are for informational purposes.